Back to News
Market Impact: 0.42

Up 214% This Year, Is It Too Late to Buy Micron Stock?

Artificial IntelligenceTechnology & InnovationCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst InsightsMarket Technicals & Flows
Up 214% This Year, Is It Too Late to Buy Micron Stock?

Micron shares are up 214% year to date as AI data-center demand for high-bandwidth memory drives revenue growth, with fiscal Q2 revenue soaring 196% year over year to $23.9B. The company expects next quarter gross margin of 81% and EPS of $19.15 at the midpoint, but the article warns the memory market remains cyclical and may eventually revert as supply catches up. Micron still trades at just 7.6x forward earnings, below Nvidia’s 24x and the Nasdaq’s 26x estimate.

Analysis

The market is beginning to re-rate memory not as a commodity subcycle, but as a constrained input to AI capex. That matters because the first-order beneficiary is MU, but the second-order winners are the companies that can monetise the same bottleneck without having to fund capacity expansion themselves — namely equipment, advanced packaging, and data-center networking vendors. The bigger implication is that hyperscalers may be forced to trade compute mix toward memory-rich architectures, which can compress ROI on AI deployments and eventually slow incremental capex growth. The key risk is timing mismatch: pricing power in memory can stay exceptional for several quarters even if the medium-term supply response is inevitable. Once capacity additions start to hit the market, the margin compression is usually abrupt, not gradual, because the industry has low differentiation and inventory re-stocking reverses quickly. MU’s current multiple is cheap because the market is discounting exactly that fade; the right question is whether today’s earnings power is a peak or a new plateau driven by HBM scarcity and more disciplined supply. The contrarian read is that consensus may be underestimating how long AI-related memory scarcity can persist if leading-edge packaging and test constraints become the real bottleneck rather than wafer capacity. If so, the cycle could stay tighter for longer than the historical playbook suggests, supporting earnings even if unit growth normalizes. But if capex announcements from MU and peers remain aggressive into the next 2-3 quarters, the stock should trade more like a cash-flow call option than a durable compounder.